RPG Life Sciences Ltd

RPGLIFE

Company Profile

  • Business description

    RPG Life Sciences Ltd is engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). The company is exclusively engaged in the pharmaceutical business and operates across Domestic Formulations, International Formulations, and Active Pharmaceutical Ingredients (API). It offers a range of high-value synthetic APIs in the general therapeutic category, with a growing product portfolio covering immunosuppressants, antipsychotics, anti-anginal, anthelmintics, anti-convulsant, anti-spasmodic, and other therapeutic categories. The company has a presence in Europe, Latin America, and Asia, and is making forays into the US markets. It has one reportable business segment, Pharmaceuticals.

  • Contact

    463, Dr. Annie Besant Road
    RPG House
    Worli
    MumbaiMH400030
    IND

    T: +91 2269757100

    https://www.rpglifesciences.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2027

    Employees

    1,778

Stocks News & Analysis

stocks

Ask the analyst: Where does GYG stand following its US exit?

All roads lead back home for Guzman Y Gomez.
stocks

Chart of the Week: The long term headwinds facing copper shares

The key factors challenging the bull case for copper demand.
stocks

Australia’s oldest REIT undervalued

This REIT remains undervalued as trophy properties shine through.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,048.3074.600.83%
CAC 408,508.0733.210.39%
DAX 4025,779.31198.430.78%
Dow JONES (US)52,900.07594.831.14%
FTSE 10010,679.0326.160.25%
HKSE23,350.03295.001.28%
NASDAQ25,832.67207.36-0.80%
Nikkei 22569,744.071,010.921.47%
NZX 50 Index13,618.4236.230.27%
S&P 5007,483.240.010.00%
S&P/ASX 2008,844.4075.100.86%
SSE Composite Index4,043.6414.740.37%

Market Movers